SCHEMBL29201731

SCHEMBL29201731

Cc1ccc(S(=O)(=O)OCCC2CCN(C(=O)OCc3ccccc3)CC2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 9/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
CYP2C19 P33261 1/20 0.51
F13A1 P00488 3/20 0.49
TGM2 P21980 3/20 0.49
TGM1 P22735 3/20 0.49
MMP1 P03956 1/20 0.49
MMP2 P08253 1/20 0.49
MMP3 P08254 1/20 0.49
MMP7 P09237 1/20 0.49
MMP9 P14780 1/20 0.49
MMP8 P22894 1/20 0.49
HTT P42858 1/20 0.49
CYP2D6 P10635 3/20 0.48
CYP2C9 P11712 3/20 0.48
CHRM4 P08173 1/20 0.48
FAAH O00519 1/20 0.48
KDM4E B2RXH2 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7280409 0.94 GRIN2B (0.52) GRIN2BSMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL7282292 0.92 GRIN2B (0.50) GRIN2BSMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL4828216 0.89 GRIN2B (0.61) GRIN2BSMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL1325695 0.87 SMN1; SMN2 (0.52) GRIN2BSMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL13194581 0.86 SMN1; SMN2 (0.47) GRIN2BSMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL28977999 0.86 LMNA (0.57) GRIN2BSMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL459957 0.86 SMN1; SMN2 (0.58) GRIN2BSMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL19475555 0.86 GRIN2B (0.57) GRIN2BSMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL17063265 0.86 GRIN2B (0.57) GRIN2BSMN1; SMN2NPC1RAB9ACYP2C19
SCHEMBL5452029 0.85 GRIN2B (0.53) GRIN2BSMN1; SMN2NPC1RAB9ACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4606803-A1 KRAS G12D DEGRADATION AGENT, AND PREPARATION METHOD AND USE THEREFOR Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. (CN) 2025-08-27 EP disclosed
CN-117964623-A Targeted protein degradation compound and preparation method and application thereof 上海领泰生物医药科技有限公司 2024-05-03 CN disclosed
CN-117917416-A KRAS G12D degradation agent and preparation method and application thereof 上海领泰生物医药科技有限公司 2024-04-23 CN disclosed
CN-115244053-B Targeted protein degradation compound and preparation method and application thereof 上海领泰生物医药科技有限公司 2024-01-30 CN disclosed
CN-115244053-A Targeted protein degradation compound and preparation method and application thereof 上海领泰生物医药科技有限公司 2022-10-25 CN disclosed
WO-2022028547-A1 COMPOUND FOR TARGETING AND DEGRADING PROTEIN, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海领泰生物医药科技有限公司 2022-02-10 WO disclosed